Search research articles
Contact Us
Filters
Showing results (31-40 of 342) with videos related to
Page
of 35
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 27, 2021
Dengue fever in a multiple sclerosis patient taking Ocrelizumab
Tommaso Guerra, Luca Bollo, Maria Trojano, et al.
Epilepsy & Behavior : E&B
|
October 28, 2022
On epilepsy perception: Unravelling gaps and issues
Giovanni Falcicchio, Francesco Negri, Maria Trojano, et al.
Current Opinion in Neurology
|
June 8, 2022
Interrogating large multiple sclerosis registries and databases: what information can be gained?
Maria Trojano, Tomas Kalincik, Pietro Iaffaldano, et al.
Experimental Neurology
|
March 6, 2007
Immunomodulatory properties of increased levels of liver X receptor beta in peripheral blood mononuclear cells from multiple sclerosis patients
Maurizio Giorelli, Paolo Livrea, Mauro Giuseppe Minervini, et al.
Expert Review of Neurotherapeutics
|
June 21, 2022
Seizure medication and planned pregnancy: balancing the risks and outcomes
Angela La Neve, Giovanni Falcicchio, Maria Trojano, et al.
European Journal of Clinical Pharmacology
|
July 15, 2020
Durvalumab and multiple sclerosis: a causal link or simple unmasking?
Francesca Caputo, Alessia Manni, Pietro Iaffaldano, et al.
Internal and Emergency Medicine
|
April 29, 2022
Interdisciplinary approach to opportunistic infections: staphylococcal meningitis in a patient with multiple sclerosis on treatment with dimethyl fumarate
Luca Bollo, Francesca Caputo, Damiano Paolicelli, et al.
Brain and Behavior
|
December 16, 2020
A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review
Mosè Parisi, Alessia Manni, Francesca Caputo, et al.
Therapeutic Advances in Neurological Disorders
|
June 27, 2020
Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)
Francesco Patti, Andrea Visconti, Antonio Capacchione, et al.
Brain, Behavior, and Immunity
|
September 3, 2013
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis
Pietro Iaffaldano, Maddalena Ruggieri, Rosa Gemma Viterbo, et al.
Page
of 35
Search research articles
Search
Showing results (31-40 of 342) with videos related to
Sort By:
Page
of 35
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 27, 2021
Dengue fever in a multiple sclerosis patient taking Ocrelizumab
Tommaso Guerra, Luca Bollo, Maria Trojano, et al.
Epilepsy & Behavior : E&B
|
October 28, 2022
On epilepsy perception: Unravelling gaps and issues
Giovanni Falcicchio, Francesco Negri, Maria Trojano, et al.
Current Opinion in Neurology
|
June 8, 2022
Interrogating large multiple sclerosis registries and databases: what information can be gained?
Maria Trojano, Tomas Kalincik, Pietro Iaffaldano, et al.
Experimental Neurology
|
March 6, 2007
Immunomodulatory properties of increased levels of liver X receptor beta in peripheral blood mononuclear cells from multiple sclerosis patients
Maurizio Giorelli, Paolo Livrea, Mauro Giuseppe Minervini, et al.
Expert Review of Neurotherapeutics
|
June 21, 2022
Seizure medication and planned pregnancy: balancing the risks and outcomes
Angela La Neve, Giovanni Falcicchio, Maria Trojano, et al.
European Journal of Clinical Pharmacology
|
July 15, 2020
Durvalumab and multiple sclerosis: a causal link or simple unmasking?
Francesca Caputo, Alessia Manni, Pietro Iaffaldano, et al.
Internal and Emergency Medicine
|
April 29, 2022
Interdisciplinary approach to opportunistic infections: staphylococcal meningitis in a patient with multiple sclerosis on treatment with dimethyl fumarate
Luca Bollo, Francesca Caputo, Damiano Paolicelli, et al.
Brain and Behavior
|
December 16, 2020
A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review
Mosè Parisi, Alessia Manni, Francesca Caputo, et al.
Therapeutic Advances in Neurological Disorders
|
June 27, 2020
Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)
Francesco Patti, Andrea Visconti, Antonio Capacchione, et al.
Brain, Behavior, and Immunity
|
September 3, 2013
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis
Pietro Iaffaldano, Maddalena Ruggieri, Rosa Gemma Viterbo, et al.
Page
of 35